The physiological significance of coronary aneurysms in Kawasaki disease

EuroIntervention

Volumn 7, Issue 8, 2011, Pages 944-947

  Murakami, Tomoaki ^a,b   Tanaka, Nobuhiro ^c  

^a Ichihara Center   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Coronary aneurysm; Coronary ischaemia; Fractional flow reserve; Kawasaki disease

Indexed keywords

ADOLESCENT; ADULT; ARTERIAL PRESSURE; ARTICLE; CHILD; CLINICAL ARTICLE; CORONARY ARTERY ANEURYSM; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; FRACTIONAL FLOW RESERVE; HEART HEMODYNAMICS; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POPULATION RESEARCH;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CORONARY ANEURYSM; FEMALE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HEMODYNAMICS; HUMANS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; YOUNG ADULT;

EID: 84855386639     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I8A149     Document Type: Article

References (10)

1. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger MH, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA; Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747-2771. (Pubitemid 39453026)
2. JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008) - digest version. Circ J. 2010;74:1989-2020.
3. Pijls NHJ, Van Gelder B, Van der Voort P, Peels K, Bracke FA, Bonnier HJ, el Gamal MI. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation. 1995;92:3183-3193.
4. Sonoda S, Takeuchi M, Nakashima Y, Kuroiwa A. Safety and optimal dose of intracoronary adenosine 5′-triphosphate for the measurement of coronary flow reserve. Am Heart J. 1998;135: 621-627. (Pubitemid 28164897)
5. Hamaoka K, Onouchi Z. Effects of intracoronary adenosine triphosphate on coronary flow velocity dynamics in children. Jpn Heart J. 1997;38:39-52. (Pubitemid 27136223)
6. Japanese Circulation Society Joint Research Group. Guideline for diagnosis and management of cardiovascular sequelae in Kawasaki disease. Pediatr Int. 2005;47:711-732.
7. Yoshikawa T, Suma K, Sugawara M. Hemodynamic effects of bead-shaped aneurysm in kawasaki's disease. Kokyu To Junkan. 1980;28:395-399. (Pubitemid 11048919)
8. Kato H, Sugimura T, Akagi T, Sato N, Eto G, Yamakawa R. Long-term consequences of Kawasaki disease. A10- to 21-year follow-up study of 594 patients. Circulation. 1996;94:1379-1385. (Pubitemid 26307269)
9. Onouchi Z, Hamaoka K, Sakata K, Ozawa S, Shiraishi I, Itoi T, Kiyosawa N. Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: Comparison of therapeutic regimens. Circ J. 2005;69:265-272. (Pubitemid 40410179)
10. Goldsmith HL. Blood flow and thrombosis. Thromb Diath Haemorrh. 1974;32:35-48.